Abstract:Abstract The genomic catalogue of the human microbiota has expanded dramatically in recent years, and insights derived from human microbiota genomics has vast potential to generate treatments for human diseases. However, predictably harnessing the microbiota for beneficial outcomes is currently limited by our lack of understanding of the physiology of the constituent bacteria. For instance, the functions of most of their genes are not known. Here, we systematically measure mutant phenotypes for genes from the gut commensal Bacteroides thetaiotaomicron . Using a barcoded transposon mutant library, we measured the fitness of 4,055 B. thetaiotaomicron genes across 492 experiments, including growth on 45 carbon substrates and in the presence of 57 stress-inducing compounds. Our data is in strong agreement with previous studies, and more importantly also uncovers the biological roles of poorly annotated genes. We identified 497 genes with a specific phenotype in only one or a handful of conditions, thus enabling informed predictions of gene function for a subset of these genes. For example, we identified a glycoside hydrolase important for growth on type I rhamnogalacturonan, a DUF4861 protein for glycosaminoglycan utilization, a DUF1080 protein for disaccharide utilization, and a tripartite multidrug resistance system specifically important for bile salt tolerance. Our approach can be applied to other members of the human microbiota to experimentally characterize their genes.

Streamlined Genetic Manipulation of Diverse Bacteroides and Parabacteroides Isolates from the Human Gut Microbiota

Establishing genetic manipulation for novel strains of human gut bacteria

Advances in synthetic biology toolboxes paving the way for mechanistic understanding and strain engineering of gut commensal Bacteroides spp. and Clostridium spp.

Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome

Genetic manipulation of the human gut bacterium Eggerthella lenta reveals a widespread family of transcriptional regulators

Engineer Probiotic Bifidobacteria for Food and Biomedical Applications - Current Status and Future Prospective.

CRISPR/Cas-Based Genome Editing for Human Gut Commensal Bacteroides Species

Large-scale chemical-genetics of the human gut bacterium Bacteroides thetaiotaomicron

Genetic Engineering of Resident Bacteria in the Gut Microbiome

Genome engineering of the human gut microbiome

Advanced probiotics: bioengineering and their therapeutic application

Decoding the microbiome: advances in genetic manipulation for gut bacteria

Targeted Approaches for In Situ Gut Microbiome Manipulation

Phages to the rescue: in situ editing of the gut microbiota

A Toolbox for Genetic Manipulation in Intestinal Clostridium Symbiosum

Engineering Diagnostic and Therapeutic Gut Bacteria

Functional genetics of human gut commensal Bacteroides thetaiotaomicron reveals metabolic requirements for growth across environments

A droplet-based microfluidic approach to isolating functional bacteria from gut microbiota

Metabolic Engineering of Commensal Bacteria for Gut Butyrate Delivery and Dissection of Host-Microbe Interaction.

Genetically Engineered Bacteria for Treating Human Disease

In situ targeted base editing of bacteria in the mouse gut